Zobrazeno 1 - 10
of 79
pro vyhledávání: '"Salvatore, Leotta"'
Autor:
Manlio Fazio, Vittorio Del Fabro, Nunziatina Laura Parrinello, Alessandro Allegra, Uroš Markovic, Cirino Botta, Fabrizio Accardi, Iolanda Donatella Vincelli, Salvatore Leotta, Federica Elia, Benedetta Esposito, Bruno Garibaldi, Gabriele Sapuppo, Alessandra Orofino, Alessandra Romano, Giuseppe A. Palumbo, Francesco Di Raimondo, Concetta Conticello
Publikováno v:
Current Oncology, Vol 30, Iss 11, Pp 9710-9733 (2023)
Multiple myeloma is a chronic hematologic malignancy that obstinately tends to relapse. Basic research has made giant strides in better characterizing the molecular mechanisms of the disease. The results have led to the manufacturing of new, revoluti
Externí odkaz:
https://doaj.org/article/640ba9bbb0e445b1ae41559c017963b1
Autor:
Andrea Duminuco, Marina Parisi, Giulio Antonio Milone, Alessandra Cupri, Salvatore Leotta, Giuseppe A. Palumbo, Nunziatina Laura Parrinello, Grazia Scuderi, Anna Triolo, Giuseppe Milone
Publikováno v:
Hematology Reports, Vol 15, Iss 4, Pp 555-561 (2023)
Monoclonal T-cell lymphocytosis has been reported in patients with concomitant autoimmune diseases, viral infections, or immunodeficiencies. Referred to as T-cell large granular lymphocytic leukemia (T-LGLL), most cases cannot identify the triggering
Externí odkaz:
https://doaj.org/article/b363952c5cb6454887231743dd406b7d
Autor:
Andrea Duminuco, Uros Markovic, Nunziatina Laura Parrinello, Luca Lo Nigro, Elisa Mauro, Calogero Vetro, Marina Parisi, Cinzia Maugeri, Paolo Fabio Fiumara, Giuseppe Milone, Alessandra Romano, Francesco Di Raimondo, Salvatore Leotta
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Blinatumomab is a bispecific anti-CD3 and anti-CD19 antibody that acts as a T-cell engager: by binding CD19+ lymphoblasts, blinatumomab recruits cytotoxic CD3+ T-lymphocytes to target the cancer cells. Here we describe seven different patients affect
Externí odkaz:
https://doaj.org/article/6d1ea67282854a9192f0384a596efbcd
Autor:
Andrea Duminuco, Antonella Nardo, Alessandra Orofino, Alessandra Romano, Amalia Stefania Figuera, Annalisa Chiarenza, Uros Markovic, Laura Caruso, Giuliana Giunta, Salvatore Leotta, Giuseppe Milone, Alessandra Cupri, Concetta Conticello, Vittorio Del Fabro, Elisa Mauro, Cinzia Maugeri, Calogero Vetro, Marina Parisi, Francesco DI Raimondo, Giuseppe Palumbo
Publikováno v:
HemaSphere, Vol 7, p e4986333 (2023)
Externí odkaz:
https://doaj.org/article/d68e541d16fd4c7a9d6233c6a640b80e
Autor:
Anna Ferrari, Delia Cangini, Andrea Ghelli Luserna di Rorà, Annalisa Condorelli, Marta Pugliese, Giovanni Schininà, Sebastiano Cosentino, Eugenio Fonzi, Chiara Domizio, Giorgia Simonetti, Salvatore Leotta, Giuseppe Milone, Giovanni Martinelli
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 11 (2023)
High-risk relapsed/refractory adult Philadelphia-negative (Ph−) B-cell acute lymphoblastic leukemia (B-ALL) is a great challenge due to limited possibilities to achieve and maintain a complete response. This also applies to cases with extramedullar
Externí odkaz:
https://doaj.org/article/bc12e74fa7e04b59af26cedd0981c4a3
Autor:
Patrizia Chiusolo, Nicoletta Orlando, Sabrina Giammarco, Monica Rossi, Elisabetta Metafuni, Salvatore Leotta, Giuseppe Milone, Caterina Giovanna Valentini, Maria Bianchi, Filippo Frioni, Claudio Pellegrino, Federica Sorà, Luigi Maria Larocca, Simona Sica, Andrea Bacigalupo, Luciana Teofili
Publikováno v:
Haematologica, Vol 108, Iss 1 (2022)
Externí odkaz:
https://doaj.org/article/5a5c9fcca1ce4def8a4725d552fd98be
Autor:
Massimo Martino, Annalisa Pitino, Mercedes Gori, Benedetto Bruno, Alessandra Crescimanno, Vincenzo Federico, Alessandra Picardi, Stefania Tringali, Claudia Ingrosso, Paola Carluccio, Domenico Pastore, Gerardo Musuraca, Annalisa Paviglianiti, Adriana Vacca, Bianca Serio, Gabriella Storti, Nicola Mordini, Salvatore Leotta, Michele Cimminiello, Lucia Prezioso, Barbara Loteta, Anna Ferreri, Fabrizia Colasante, Emanuela Merla, Luisa Giaccone, Alessandro Busca, Maurizio Musso, Renato Scalone, Nicola Di Renzo, Serena Marotta, Patrizio Mazza, Pellegrino Musto, Immacolata Attolico, Carmine Selleri, Filippo Antonio Canale, Marta Pugliese, Giovanni Tripepi, Gaetana Porto, Giovanni Martinelli, Angelo Michele Carella, Claudio Cerchione
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Despite effective treatments, cytomegalovirus (CMV) continues to have a significant impact on morbidity and mortality in allogeneic stem cell transplant (allo-SCT) recipients. This multicenter, retrospective, cohort study aimed to evaluate the reprod
Externí odkaz:
https://doaj.org/article/e505e90b69714fdf86208ecf0841bd1a
Autor:
Uros Markovic, Alessandra Romano, Vittorio Del Fabro, Claudia Bellofiore, Anna Bulla, Marina Silvia Parisi, Salvatore Leotta, Massimo Gentile, Clotilde Cangialosi, Iolanda Vincelli, Giuseppe Mineo, Marco Rossi, Massimo Poidomani, Giuseppina Uccello, Cinzia Maugeri, Donato Mannina, Vanessa Innao, Francesco Di Raimondo, Concetta Conticello
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundThe anti-CD38 monoclonal antibody daratumumab is approved as a single agent for the treatment of patients with relapsed/refractory multiple myeloma (RRMM) who received at least three prior lines of therapy, including proteasome inhibitor an
Externí odkaz:
https://doaj.org/article/62d114c5feae4199a24298a5f48db9e5
Autor:
Salvatore Leotta, Giuseppe Sapienza, Maria Grazia Camuglia, Giuseppe Avola, Annalia Di Marco, Gaetano Moschetti, Angelo Curto Pelle, Uros Markovic, Giulio Antonio Milone, Alessandra Cupri, Oriana Bianco, Viviana Frontini, Andre Spadaro, Anna Elisa Marchese, Roberto Crocchiolo, Giuseppe Milone
Publikováno v:
Frontiers in Immunology, Vol 10 (2020)
Assays of cytokines in the plasma at the onset of graft-vs. -host disease (GVHD) can predict disease severity and treatment-related mortality (TRM); however, the optimal time during which cytokines should be tested and the specific panel of cytokines
Externí odkaz:
https://doaj.org/article/7780fa4b78d640048bf46fcdecffcbf6
Autor:
Giuseppe Milone, Concetta Conticello, Salvatore Leotta, Maria Grazia Michieli, Massimo Martino, Anna Lia Di Marco, Andrea Spadaro, Alessandra Cupri, Annalisa Condorelli, Giulio Antonio Milone, Uros Markovic, Roberta Sciortino, Giovanni Schininà, Gaetano Moschetti, Loredana Villari, Riccardo Saccardi
Publikováno v:
Leukemia Research Reports, Vol 14, Iss , Pp 100227- (2020)
In CD34+ cells mobilization of patients with multiple myeloma (MM), the use of Cyclophosphamide (CTX) at a dose of 2 g/m2 has low efficacy although also lower toxicity. The suboptimal mobilizing effect of low-dose CTX, however, may be overcome by ple
Externí odkaz:
https://doaj.org/article/6b464e53422845e59db094b3cb1deaa2